Achillion’s NS4A antagonists in hep C gets US patent (PharmaBiz)
Posted in Patents on April 20th, 2009Achillion’s NS4A antagonists in hep C gets US patent (PharmaBiz)
Achillion Pharmaceuticals, Inc, a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, announced that the US Patent & Trademark Office has granted Achillion US Patent No 7,476,686 related to the Achillion NS4A antagonists to treat the hepatitis C virus (HCV). This new patent, entitled ‘Substituted Aryl Thioureas and related …






